The three countries within the East African leDEA Regional Consortium (Kenya, Uganda, Tanzania) have adult HIV prevalence rates ranging between 5-10%.Since the advent of the global antiretroviral therapy (ART) rollout in 2003, there has been a dramatic increase in the percent coverage of those estimated in need of ART (based on the 2006 WHO guidelines), from essentially no patients on in 2003, to 65% coverage in Kenya, 53% in Uganda, and 44% in Tanzania by the end of 2009. Though this dramatic scale-up of HIV treatment has had a positive impact on mortality rates, key questions remain throughout the course of a patient's engagement in care, from the pre- ART period through ART-initiation, initial clinical response to ART and regimen durability (occurrence of adverse events and drug resistance), to long-term maintenance, loss to follow-up (LTFU), and death. It is the long-range goal of this consortium is to provide answers to the questions that clinicians, programs, and ministries of health consider fundamental to the evolution and sustainability of their long term HIV care and treatment strategies. In the next funding cycle, we will address these questions by enhancing data collection in key areas as well as merging existing data sources to better assess and inform the ART rollout in East Africa. We are optimally placed to lead this endeavor as our consortium includes representative HIV-clinics, a harmonized regional database, as well as physicians, epidemiologists, and analysts with expertise in implementation research and a solid understanding of the strengths and limitations of existing data sources. Our top priorities for the next phase of the EA-leDEA Consortium are to:
Aim 1 : Determine the short and long-term outcomes of adults and children along the entire spectrum of HIV care and examine patient and site-level factors associated with these outcomes;
Aim 2 : Assess the penetrance and outcomes of prevention of mother to child transmission of HIV (pMTCT) strategies;
Aim 3 : Monitor the translation of evidence into practice for managing co-infections with an emphasis on Tuberculosis (TB);
Aim 4 : Determine the prevalence, incidence, determinants and outcomes of malignancies in East Africa with a focus on Kaposi's sarcoma (KS) and cervical cancer.

Public Health Relevance

Through these efforts, we will enhance our understanding about the HIV-epidemic in its sub- Saharan Africa context, provide insights on the optimal structure and impact of care and treatment programs, expand the set of tools available to inform implementation and operations research in resource-constrained settings and inform policy among stakeholders and decision makers at every level in the region as well as the broader HIV/AIDS scientific community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI069911-09
Application #
8705354
Study Section
Special Emphasis Panel ()
Program Officer
Zimand, Lori B
Project Start
2006-08-05
Project End
2016-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
9
Fiscal Year
2014
Total Cost
$1,777,711
Indirect Cost
$278,713
Name
Indiana University-Purdue University at Indianapolis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Wringe, Alison; Moshabela, Mosa; Nyamukapa, Constance et al. (2017) HIV testing experiences and their implications for patient engagement with HIV care and treatment on the eve of 'test and treat': findings from a multicountry qualitative study. Sex Transm Infect 93:
Moshabela, Mosa; Bukenya, Dominic; Darong, Gabriel et al. (2017) Traditional healers, faith healers and medical practitioners: the contribution of medical pluralism to bottlenecks along the cascade of care for HIV/AIDS in Eastern and Southern Africa. Sex Transm Infect 93:
Brennan, Alana T; Davies, Mary-Ann; Bor, Jacob et al. (2017) Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa? AIDS 31:147-157
Mahy, Mary; Penazzato, Martina; Ciaranello, Andrea et al. (2017) Improving estimates of children living with HIV from the Spectrum AIDS Impact Model. AIDS 31 Suppl 1:S13-S22
Anderegg, Nanina; Johnson, Leigh F; Zaniewski, Elizabeth et al. (2017) All-cause mortality in HIV-positive adults starting combination antiretroviral therapy: correcting for loss to follow-up. AIDS 31 Suppl 1:S31-S40
Fritz, Cristin Q; Blevins, Meridith; Lindegren, Mary Lou et al. (2017) Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014. J Int AIDS Soc 20:20933
Hu, Liangyuan; Hogan, Joseph W; Mwangi, Ann W et al. (2017) Modeling the causal effect of treatment initiation time on survival: Application to HIV/TB co-infection. Biometrics :
Bakoyannis, Giorgos; Yu, Menggang; Yiannoutsos, Constantin T (2017) Semiparametric regression on cumulative incidence function with interval-censored competing risks data. Stat Med 36:3683-3707
Renju, Jenny; Moshabela, Mosa; McLean, Estelle et al. (2017) 'Side effects' are 'central effects' that challenge retention in HIV treatment programmes in six sub-Saharan African countries: a multicountry qualitative study. Sex Transm Infect 93:
Ondenge, Ken; Renju, Jenny; Bonnington, Oliver et al. (2017) 'I am treated well if I adhere to my HIV medication': putting patient-provider interactions in context through insights from qualitative research in five sub-Saharan African countries. Sex Transm Infect 93:

Showing the most recent 10 out of 98 publications